Binding sites for six distinct nuclear factors on the 75-base-pair repeat of the Moloney murine leukemia virus enhancer have been identified by an electrophoretic mobility shift assay combined with methylation interference. Three of these factors, found in WEHI 231 nuclear extracts, which we have named LVa, LVb, and LVc (for leukemia virus factors a, b, and c) have not been previously identified. Nuclear factors that bind to the conserved simian virus 40 corelike motif, the NF-1 motif, and the glucocorticoid response element were also detected. Testing of multiple cell lines showed that most factors appeared ubiquitous, except that the NF-1 binding factor was found neither in nuclear extracts from MEL cells nor in the embryonal carcinoma cell lines PCC4 and F9, and core-binding factor was relatively depleted from MEL and F9 nuclear extracts.
Eucaryotic transcriptional enhancers are cis-acting regions of DNA that can potentiate transcription from autologous and heterologous promoters, independent of orientation and location relative to the promoter (1, 2, 17, 19, 31, 45) . There is substantial evidence that enhancers contain binding sites for proteins (33, 37, 42, 43) , and it is generally assumed that the association of these proteins must mediate the transcriptional enhancement, although the mechanism for this process is unknown.
Dissection of enhancers by DNA mutational analysis (46) and, more recently, by protein-binding assays (3, 36, 43) has revealed a striking complexity in the composition and organization of enhancer sequences. There are generally multiple binding sites for nuclear factors within an enhancer, and they are often present in several copies. Viral enhancers, in particular, are composed of an impressive patchwork of conserved sequence motifs, found elsewhere in both cellular enhancers and other viral enhancers. The simian virus 40 (SV40) enhancer, for example, contains a core motif (TGTG-GTAA) that is also found in the immunoglobulin K and ,. enhancers and in the enhancers associated with the murine leukemia viruses, polyomavirus, and BK viruses (41) . A sequence (GGGGACTTTCC) found in the immunoglobulin K enhancer that binds a factor found only in B cells (36) and a conserved octanucleotide motif (ATTTGCAT) that is located 70 base pairs (bp) upstream of the transcription initiation site in immunoglobulin genes and also within the ,u enhancer are also present in the SV40 enhancer (13, 30, 34, 38) .
While the papovavirus enhancers have been well characterized, analysis of retroviral enhancers has not progressed as far. C-type retroviruses, as typified by Moloney murine leukemia virus (Mo-MuLV), contain enhancer elements in the U3 region of the viral genome (22) . In Mo-MuLV, the enhancer is organized as a 75-bp repeated sequence located approximately 160 bp 5' to the viral cap site. With one notable exception, the Mo-MuLV enhancer is transcriptionally active in all cell types (18, 24) . The disease specificity (thymic leukemia) of Mo-MuLV, however, is conferred by the U3 region of the genome (4, 9) , indicating that subtle * Corresponding author. differences in transcriptional activity may influence the tissue specificity and general pathology of the disease.
To understand some of the interesting biological properties of retroviruses, it is necessary to study the transcriptional regulation conferred by the enhancer sequences. To this end, we have undertaken an analysis of the 75-bp repeat region of the Mo-MuLV enhancer. In this report, we identify six distinct binding sites for nuclear factors, as detected by an electrophoretic mobility shift assay. Methylation interference techniques have enabled us to define the sequence motifs for these nuclear factors and to demonstrate a considerable overlap of binding sites, indicating the complexity of organization of this viral enhancer.
MATERIALS AND METHODS
Extracts and cell lines. Nuclear extracts were made from tissue culture cell lines by the protocol of Dignam et al. (11) and usually contained between 3 and 8 mg of protein per ml. The following mouse cells were used: WEHI 231, a mouse B-cell line; EL4, a mouse T-cell line; MEL, a mouse erythroleukemia cell line; L cell, a mouse fibroblast; NIH 3T3, a mouse fibroblast; and PCC4 and F9, undifferentiated mouse embryonal carcinoma cells.
Column fractions of WEHI 231 nuclear extracts were kindly provided by L. Staudt. Briefly, the nuclear extract in buffer D (20 mM HpaII8058, HpaII8059-XbaI81u1, and HaeIII74-HaeIII8023 fragments were isolated and subcloned into the SmaI site of SP64 (see Fig. 1 for a map of the region). Approximately 500-bp competitor fragments containing the inserts were prepared by cutting in the vector sequences of SP64 (NaeI and BstNI). The competitor fragments were isolated from 2% low-melting agarose gels by three extractions with phenol and one with chloroform followed by ethanol precipitation. The Methylation interference experiments. End-labeled DNA fragments were partially methylated at guanine residues as detailed by Maxam and Gilbert (26) , with the following modification. The reaction was quenched with 1.5 M sodium acetate (pH 7.0)-i M 3-mercaptoethanol-0.0025% polyacrylamide carrier. Methylated DNA was ethanol precipitated twice, rinsed with 70% ethanol, and used in binding reactions. For a preparative binding, the usual conditions were scaled up 10-fold. Binding and electrophoresis were as described above. After electrophoresis, the gel was wrapped with Saran wrap and exposed wet for 4 to 6 h at room temperature. The complex and free fragments were excised, cast into 1% agarose gels, and electrophoresed onto DEAEpaper (12 (14, 16) .
With this methodology, we found that WEHI 231 nuclear proteins bind to a number of sites within the Mo-MuLV enhancer. This became clear when fragment I was used because a multiplicity of protein-DNA complexes was observed (Fig. 2, lane 1) . These bands could be partially resolved by chromatographically fractionating the WEHI 231 nuclear extract through heparin-agarose or phosphocellulose by using a three-step elution (0. 25 (20) . Endlabeled probes were partially methylated on guanines and used in the binding reactions. The binding mixture was then fractionated by electrophoresis through polyacrylamide gels. Bands corresponding to both the complex and free DNA were eluted from the gel, subjected to piperidine cleavage, and analyzed by electrophoresis through polyacrylamideurea sequencing gels. Methylated G residues that interfered with the binding of the factor were depleted from the protein-DNA complex band and appeared as gaps in the sequence ladder relative to free DNA. With the 0.45 M KCl phosphocellulose fraction with fragment VII, the complex showed interference by methylation of two G residues on the coding strand and one G on the noncoding strand (Fig. 3 , asterisks in lanes 1 to 4). This defined a site immediately 5' to the EcoRV cleavage site, correlating well with the in vivo 5' deletion data generated by Schulze et al. , that localized the 5' boundary of an important regulatory sequence element of Mo-MSV to the 5'-CAGGAT-3' motif immediately 5' to the EcoRV site (see is expanded below. The internal fragments PvuII7938-PvuII8012 (I) HaeIII7949-HaeIII7993 (VII), EcoRV7960-EcoRV8034 (III), HpaII7984-HpaIU8o09 (V), HaeIII79%-HaeIII8023 (VIII), PvuII8013-XbaI8,11 (II), EcoRV8035-XbaI8,11 (IV) , and HpaII8059-XbaI811 (VI) were subcloned into the SmaI site of SP64, and the resultant plasmids were used to generate end-labeled probes. Fragments IX to XVII were prepared from plasmids containing fragments I to VIII. The probes and competitor fragments are referred to by Roman numerals (I to XVII) throughout the text.
the LVb site on the coding strand and the LVc site on the noncoding strand (Fig. 3 , lanes 5 to 8). Although LYb was significantly depleted in the 0.25 M KCl fraction, the small amount remaining could apparently bind with LVc on the same DNA fragment. The association of both LVb and LVc on the same fragment to form a complex having a mobility distinct from those of LVb and LVc binding alone indicates that the distance between theLVb and LVc sites is sufficient to accommodate both proteins simultaneously. The arrow near lane 5 in Fig. 3b indicates a hypersensitive cleavage site in the LVb-LVc-DNA complex, between the LVb-and LVc-binding sites. We showed in an independent experiment that this did not depend on G-specific cleavage by isolating the protein-DNA complex and free DNA bands from a preparative gel and, without piperidine cleavage, analyzing the DNA in a denaturing polyacrylamide-urea gel, next to a sequence ladder. A single band migrating at the same position was seen in the protein-DNA band but not in free DNA (data not shown). This suggests that the association of LVb and LVc on the same fragment may render the DNA between these sites sensitive to cleavage by an endogenous endonuclease found in the nuclear extract (or possibly the LVb or LVc factors themselves).
Characterization of LVa. A third Mo-MuLV binding factor, which we call LVa, was found to bind to fragment VIII, a region covering the PvuII8012 site (Fig. 4, lane 1) . Nucleotides in the PvuII site seemed important for this binding because the complex was not found with fragment XIV or XV at the same protein/poly(dIC) ratio [4 ,ug of protein to 1.0 ,ug of poly(dIC)] used for fragment VIII (data not shown). This complex could be specifically competed for by addition of an unlabeled competitor DNA fragment spanning the PvuII site (fragment V) (lane 2) but not by a nonoverlapping fragment (fragment XI) (lane 3). The methylation interference assay on this complex from unfractionated WEHI 231 nuclear extracts (data not shown) localized important contact G residues on the coding strand immediately over the PvuII site (see Fig. 6 ). Figure 4 , lanes 4 to 7, shows the methylation interference pattern generated on fragment VIII in a 0.45 M KCI heparin fraction. At a ratio of 12 ,ug of protein to 1.0 ,ug of poly(dIC), interference was apparent at G residues within both the LVa site (see asterisks, lane 4) and the adjacent glucocorticoid response element (GRE) site (see bracket, lane 4), for reasons that will be discussed in the following section.
Detection of factors binding to conserved sequence motifs: To detect binding specific for the GRE, it was necessary to use a probe that truncated the binding site for LVa at the Pvu118012 site. When fragment XIV was used in the gel mobility shift assay, specific complexes were most evident at a protein/poly(dIC) ratio of 24 ,ug of protein to 1.0 ,ug of poly(dIC) (Fig. 5, lane 1) . The GRE complex was no longer detectable at the protein/poly(dIC) ratio [4 jig of protein to 1.0 ,ug of poly(dIC)] used to visualize the LVa complex on fragment VIII containing the LVa and GRE sites in unfractionated nuclear extracts (lanes 3 and 4) . Fig. 6 ).
Both LVa and the GRE-binding factor elute from heparin in the 0.45 M KCl step, and the protein-DNA complexes comigrate in the electrophoretic mobility shift assay. At the relatively high protein/poly(dIC) ratios used to generate the methylation interference on fragment VIII (Fig. 4) , both the GRE and LVa complexes are present in the isolated band and thus show interference at both sites.
Binding to the NF-1 motif. The 5' end of the conserved GRE motif in the Mo-MuLV enhancer overlaps the 3' end of a motif with a 7-to 8-bp homology to the consensus sequence for another well-characterized protein, nuclear factor 1 (NF-1) (28 Fig. 5, lane 13 ) that was also competed specifically for by fragment I but not by fragment VIII (Fig. 5, lanes 11 to 13) . A complex with similar mobility and an identical methylation interference pattern was found with a longer probe (fragment IV). The methylated residues that interfered with binding are shown in Fig. 6 .
There is another sequence with a 7-to 8- Fig. 1 ). An attempt was made to normalize for LVb in this experiment and then to compare the relative levels of core-binding factor by using the same amounts of extract used in lanes 1 to 7 and a constant amount of VOL. 7, 1987 Binding to the NFl-consensus. Probe XVI was prepared by end labeling fragment VI and recutting at AvaII. Fragment VI was subcloned by filling in the 5' overhang generated by HpaII with the Klenow fragment of DNA polymerase I and ligating into the SmaI site of SP64. The first nucleotide (C residue, position 8059) of the NF-1 site is therefore preserved and flanked by polylinker sequences. Recutting the VI probe with AvaIl truncates the GRE site at its 3' end, probably resulting in destabilization of that complex. Lanes: 8, binding reaction mixture contained 50,000 cpm of probe XVI, 12 ,ug of protein from WEHI 231 nuclear extracts, and 1 ,ug of poly(dIC); 9, binding conditions were the same as those in lane 8, with the addition of 100 ng of unlabeled fragment I, which spans the NF-1 site; 10, binding on fragment XVI in the presence of 100 ng of unlabeled fragment VIII, containing the GRE site (the band indicated by * in lane 8 competes specifically with fragment I, containing NF-1 site, but not with fragment VIII); 11, Binding to a longer fragment (VI) containing the NF-1 and GRE site, plus sequences between the 3' end of the direct repeat and the Xba18111 site. Binding reaction mixtures contained 50,000 cpm of probe VI, 12 jig of protein, and 1 jig of poly(dIC). The protein-DNA complex indicated by * in lane 13 was competed for specifically by 100 ng of unlabeled fragment I but not fragment VIII (100 ng). The methylation interference pattern obtained for this protein-DNA complex demonstrated that the factor contacted the DNA at G residues within the NF-1 consensus sequence (see Fig. 6 ). (c) Binding to the core motif. Lane poly(dIC). Fragment XI, used to detect the core-binding factor, also contains the LVc-binding site. Interference analysis on the predominant complex formed on fragment XI identified protein-DNA contacts at nucleotides within the core consensus sequence but not in the LVc site. It is evident that although all of the extracts contained the LVb-binding factor, some lacked or were greatly deficient in the core-binding factor (Fig. 7, lanes 8 to 14) . Specifically, MEL and F9 cells were relatively depleted of the corebinding factor, and the amount of factor in PCC4 cells was also low.
The results of an analysis of many extracts and fragments are summarized in (Fig. 3b) . The dotted line extending from the box surrounding the GRE site indicates the boundaries of the DNAseI footprint generated by DeFranco and Yamamoto (8) Fig. 6 . The dotted line that extends 3 bp 5' and 10 bp 3' to the conserved motif indicates the boundaries of the DNase I footprint generated by DeFranco and Yamamoto using the purified glucocorticoid hormone receptor (8) . The 3' extension of the DNase I boundary, which gives some indication of the space that is being occupied by the protein, extends well over the site for LVa. It is obvious that the regulation of transcription must be complex, because the relative abundance or affinity of each of the various factors will presumably influence the binding of factors to adjacent sites. The dissection of the Mo-MuLV enhancer-binding sites illustrates the power of combined gel retardation assays and methylation interference techniques. Many of the protein-DNA complexes detected on the Mo-MuLV enhancer were relatively weak, and often <5% of the probe was incorporated into the complex. By first electrophoretically resolving the protein-DNA complex from free DNA, it was possible to detect complex-specific deletions in the sequence ladder that would have been impossible to visualize in the presence of the vast excess of free DNA in the binding reactions. Once the binding site for a protein-DNA complex has been defined by methylation interference, the formation of that complex in a variety of extracts can be assayed. Thus, the presence of each of the Mo-MuLV enhancer-binding factors can be determined without chromatographically fractionating each extract.
Recently, several reports have been published describing the responsiveness of the closely related Mo-MSV enhancer to steroid hormones (8, 25, 37) . It was observed that in addition to being stimulated through the binding of the glucocorticoid hormone, the Mo-MSV enhancer also contained high basal activity in the absence of stimulating hormones (8, 27) . The data presented in this report suggest that this constitutive basal activity is conferred by the association of additional factors on the Mo-MSV enhancer. The observation by Miksicek et al. (27) that the basal activity of the Mo-MSV enhancer is destroyed by restriction with EcoRV correlates well with the binding data, which demonstrated that the predominant complex on the Mo-MuLV enhancer, that generated by LVb, is localized over the EcoRV site. Examination of enhancer sequences from a variety of murine leukemia viruses, including Mo-MuLV, Mo-MSV, spleen focus-forming virus, and Friend murine leukemia virus (5) , indicates strong conservation at the LVb site, compared with LVa and LVc, suggesting that it is an especially important regulatory element in murine leukemia viruses.
Although the Mo-MuLV enhancer contains three GRE consensus motifs (the third GRE is located 5' to the first 75-bp repeat and is not included in Fig. 6 ), in vivo data suggest that, unlike Mo-MSV, it is not positively regulated by steroid hormones (29) . Comparison of the Mo-MuLV and Mo-MSV LTR sequences indicates only 6-bp differences between the two enhancers (6, 40) , all occurring outside the consensus octanucleotide AGATCAGT, that has been shown to be functional in GRE enhancement (7, 44) . This would suggest that proteins other than the glucocorticoid hormone receptor may modulate the responsiveness to steroid hormones, perhaps by influencing the availability of the GRE for hormone binding.
A survey of extracts for five of the Mo-MuLV enhancerbinding proteins revealed that one factor, NF-1, was absent in the undifferentiated embryonal carcinoma cell lines F9 and PCC4. F9 cells also did not contain significant levels of the core-binding factor. It is interesting, in this respect, that mutations of the polyoma enhancer that allow replication in EC cells were different depending upon whether the virus was isolated from F9 or PCC4 cells (15, 21, 35) . The most stringent restriction for growth was seen in F9 cells, in that mutants grown in F9 cells could also replicate in PCC4 cells, but the reciprocal was not true (39) . Our data would suggest that F9 cells may be depleted of more transcription factors than PCC4, as seen for the Mo-MuLV enhancer. It may also be that the absence of sequence-specific transcription factors is involved in determining the inactive phenotype of MoMuLV in EC cells.
The six factors that were identified may not represent all of the factors that can bind to the Mo-MuLV 75-bp repeat. The possibility that additional sites exist that bind proteins with lower affinity or of lower abundance, or whose binding is sterically hindered by the association of the factors we have identified, cannot be excluded. Because the binding and methylation interference analysis was performed with WEHI 231 nuclear extracts, additional proteins may also be present in other extracts that were not seen in WEHI 231 extracts.
